» Authors » U Pichlmeier

U Pichlmeier

Explore the profile of U Pichlmeier including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 58
Citations 972
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kroger N, Bornhauser M, Stelljes M, Pichlmeier U, Trenschel R, Schmid C, et al.
Bone Marrow Transplant . 2015 Sep; 50(12):1503-7. PMID: 26367236
TBI-based preparative regimens are considered as standard conditioning therapy for allogeneic stem cell transplantation (AHSC) in patients with ALL. We investigated toxicity and efficacy of a non-TBI-based regimen consisting of...
2.
Nestler U, Lutz K, Pichlmeier U, Stummer W, Franz K, Reulen H, et al.
Acta Neurochir (Wien) . 2014 Nov; 157(2):179-86. PMID: 25391974
Background: Many reports on glioblastoma multiforme discuss the prognostic impact of anatomical features such as cysts, necrotic changes, extent of edema or subependymal spread of tumor cells. In the present...
3.
Dieckmann K, Anheuser P, Gnoss A, Pichlmeier U
Urologe A . 2014 Oct; 53(11):1651-5. PMID: 25301239
Background: Contralateral testicular biopsy is a tool for early diagnosis of contralateral tumors in patients with testicular germ cell tumor (GCT). Though based on a high level of evidence, international...
4.
Ruf C, Gnoss A, Hartmann M, Matthies C, Anheuser P, Loy V, et al.
Andrology . 2014 Aug; 3(1):92-8. PMID: 25146646
The precursor of testicular germ cell tumours (GCTs), called testicular intra-epithelial neoplasia (TIN/CIS), is safely diagnosed immunohistologically. Testicular biopsy provides a valuable tool for early detection of GCTs in risk...
5.
Dieckmann K, Wilken S, Loy V, Matthies C, Kleinschmidt K, Bedke J, et al.
Ann Oncol . 2013 Jan; 24(5):1332-7. PMID: 23293116
Background: The treatment of testicular intraepithelial neoplasia (TIN), the progenitor of testicular germ cell tumours (GCTs), is based on little data. Patients And Methods: Two hundred and twenty-eight GCT patients...
6.
Casper J, Holowiecki J, Trenschel R, Wandt H, Schaefer-Eckart K, Ruutu T, et al.
Bone Marrow Transplant . 2011 Dec; 47(9):1171-7. PMID: 22158386
An alternative reduced-toxicity conditioning regimen for allogeneic transplantation, based on treosulfan and fludarabine, has recently been identified. The safety and efficacy of this new conditioning regimen has been investigated prospectively...
7.
Friedrich M, Schwaibold H, Wintzer O, Pichlmeier U, Huland H
Urol Oncol . 2011 Jan; 3(4):125-31. PMID: 21227117
We investigated the prevalence and clinical relevance of p53 nuclear overexpression in histologically benign bladder mucosa in patients with superficial transitional cell cancer (TCC) of the bladder to look for...
8.
Hilgendorf I, Wolff D, Gromke T, Trenschel R, Elmaagacli A, Pichlmeier U, et al.
Bone Marrow Transplant . 2010 Jun; 46(4):502-9. PMID: 20581886
Myelodysplastic syndromes (MDSs) often occur in older adults with significant comorbidities. Therefore, a reduced-toxicity conditioning regimen may be more suitable than standard conditioning regimens before allogeneic blood stem cell transplantation....
9.
Dieckmann K, Hartmann J, Classen J, Ludde R, Diederichs M, Pichlmeier U
Br J Cancer . 2008 Oct; 99(9):1517-21. PMID: 18827809
The pathogenesis of testicular germ cell tumours (GCTs) is potentially influenced by high-energy nutrition during infancy. As adult height is a proxy for childhood nutrition, we investigated the role of...
10.
Isbarn H, Budaus L, Pichlmeier U, Conrad S, Huland H, Friedrich M
Urologe A . 2008 Mar; 47(5):608-15. PMID: 18317718
Background: Adjuvant instillation therapy with chemo- or immunotherapeutic agents is an integral component in the treatment of non-muscle-invasive bladder cancer. There is, however, no general consensus on the choice of...